Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 16301-16350 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT07148141
Impact of Breast Cancer on Human Folliculogenesis
N/AActive, not recruiting
100 participants
Started: Jan 11, 2019 · Completed: Aug 31, 2025
2 conditions1 sponsor1 location
NCT03561454
A Registry of Intra-Operative Radiation Therapy (IORT) Using the Xoft ® Axxent ® eBx ™ System Patients
N/AActive, not recruiting
100 participants
Started: Jan 11, 2019 · Completed: Aug 1, 2029
1 condition2 sponsors1 location
NCT03582475
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
PHASE1Active, not recruiting
15 participants
Started: Jan 11, 2019 · Completed: Dec 1, 2026
17 conditions2 sponsors1 location
NCT04172259
ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC
PHASE2Active, not recruiting
156 participants
Started: Jan 10, 2019 · Completed: Sep 30, 2026
2 conditions3 sponsors1 location
NCT03798223
Optimal Treatment Protocol for Selective Laser Trabeculoplasty
NAActive, not recruiting
400 participants
Started: Jan 10, 2019 · Completed: Dec 31, 2027
3 conditions2 sponsors4 locations
NCT03802981
A Registry for Patients With Multifocal Ground Glass Opacities (GGOs)
N/AActive, not recruiting
338 participants
Started: Jan 9, 2019 · Completed: Jan 31, 2026
1 condition9 sponsors32 locations
NCT03786354
Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer
NAActive, not recruiting
61 participants
Started: Jan 9, 2019 · Completed: Dec 31, 2025
15 conditions1 sponsor1 location
NCT03754790
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX
PHASE3Active, not recruiting
281 participants
Started: Jan 9, 2019 · Completed: Nov 5, 2026
1 condition1 sponsor79 locations
NCT03648385
Effects of DHEA in Pulmonary Hypertension
PHASE2Active, not recruiting
24 participants
Started: Jan 9, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03778229
Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib
PHASE2Active, not recruiting
367 participants
Started: Jan 9, 2019 · Completed: May 28, 2025
1 condition2 sponsors90 locations
NCT03594734
Group Lifestyle Balance™ for Individuals With Traumatic Brain Injury (GLB-TBI)
NAActive, not recruiting
57 participants
Started: Jan 8, 2019 · Completed: Dec 30, 2026
1 condition3 sponsors1 location
NCT03775161
V-LAP™ Left Atrium Monitoring systEm for Patients With Chronic sysTOlic & Diastolic Congestive heaRt Failure
NAActive, not recruiting
45 participants
Started: Jan 8, 2019 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT03539497
Prognostic Value of Plasma Mitochondrial DNA and Cytochrome C After Cardiac Arrest
N/AActive, not recruiting
87 participants
Started: Jan 8, 2019 · Completed: Mar 30, 2024
1 condition2 sponsors1 location
NCT03595124
A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)
PHASE2Active, not recruiting
15 participants
Started: Jan 8, 2019 · Completed: Jan 23, 2026
5 conditions1 sponsor271 locations
NCT02577120
Wound Healing Endpoint and Recurrence
PHASE1/PHASE2Active, not recruiting
100 participants
Started: Jan 8, 2019 · Completed: Feb 28, 2034
7 conditions1 sponsor3 locations
NCT03844607
Combined tDCS and Cognitive Training to Reduce Impulsivity in Patients With Traumatic Brain Injury
NAActive, not recruiting
33 participants
Started: Jan 8, 2019 · Completed: Jan 1, 2025
2 conditions4 sponsors1 location
NCT03042143
Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST)
PHASE1/PHASE2Active, not recruiting
129 participants
Started: Jan 7, 2019 · Completed: Oct 31, 2026
1 condition4 sponsors1 location
NCT04317144
Web-based Follow-up to Former ICU Patients
NAActive, not recruiting
330 participants
Started: Jan 7, 2019 · Completed: Oct 7, 2025
1 condition1 sponsor1 location
NCT03738228
Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
PHASE1Active, not recruiting
40 participants
Started: Jan 7, 2019 · Completed: Sep 16, 2026
11 conditions2 sponsors16 locations
NCT03776487
Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer
PHASE2Active, not recruiting
32 participants
Started: Jan 7, 2019 · Completed: Dec 30, 2026
28 conditions2 sponsors1 location
NCT05328310
Effect of Different Antihypertensive Drugs on Central Blood Pressure
NAActive, not recruiting
110 participants
Started: Jan 6, 2019 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT03678883
9-ING-41 in Patients with Advanced Cancers
PHASE2Active, not recruiting
350 participants
Started: Jan 4, 2019 · Completed: Jan 31, 2026
25 conditions1 sponsor66 locations
NCT03116126
Noradrenergic Add-on Therapy With Guanfacine
PHASE3Active, not recruiting
148 participants
Started: Jan 4, 2019 · Completed: Aug 5, 2024
1 condition1 sponsor1 location
NCT03249831
A Blood Stem Cell Transplant for Sickle Cell Disease
PHASE1Active, not recruiting
3 participants
Started: Jan 4, 2019 · Completed: Feb 18, 2026
5 conditions2 sponsors1 location
NCT03961685
Cancer Activity and Lifestyle Measurement Study
N/AActive, not recruiting
14 participants
Started: Jan 4, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03737643
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients
PHASE3Active, not recruiting
1,407 participants
Started: Jan 4, 2019 · Completed: Mar 30, 2028
1 condition4 sponsors214 locations
NCT03687957
rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temzolomide
PHASE1/PHASE2Active, not recruiting
42 participants
Started: Jan 4, 2019 · Completed: Jan 31, 2032
1 condition3 sponsors1 location
NCT03734393
HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
NAActive, not recruiting
80 participants
Started: Jan 4, 2019 · Completed: Oct 31, 2025
1 condition2 sponsors26 locations
NCT03573349
Ketamine Associated ACC GABA and Glutamate Change and Depression Remission:
EARLY_PHASE1Active, not recruiting
18 participants
Started: Jan 3, 2019 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT03535298
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
PHASE4Active, not recruiting
800 participants
Started: Jan 3, 2019 · Completed: Jul 30, 2027
1 condition2 sponsors30 locations
NCT03851237
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
PHASE1Active, not recruiting
69 participants
Started: Jan 2, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06012656
Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay
N/AActive, not recruiting
100 participants
Started: Jan 2, 2019 · Completed: Jan 2, 2031
7 conditions1 sponsor1 location
NCT03764982
RehabNytte - A Study of Rehabilitation Processes in Specialized Care in Norway
N/AActive, not recruiting
3,793 participants
Started: Jan 2, 2019 · Completed: Dec 31, 2025
1 condition23 sponsors17 locations
NCT03674411
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
PHASE2Active, not recruiting
22 participants
Started: Jan 2, 2019 · Completed: Jun 28, 2025
11 conditions1 sponsor1 location
NCT06126679
Hyvinkää Childhood Obesity Study (HCOS), Randomized Controlled Clinical Trial for Effectiveness and Costs of a 1-year Lifestyle Intervention.
NAActive, not recruiting
80 participants
Started: Jan 2, 2019 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT03749018
Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
PHASE2Active, not recruiting
30 participants
Started: Jan 2, 2019 · Completed: Dec 31, 2025
14 conditions2 sponsors1 location
NCT03703050
Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2)
PHASE2Active, not recruiting
45 participants
Started: Jan 2, 2019 · Completed: Sep 30, 2025
1 condition1 sponsor13 locations
NCT03682536
A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve
PHASE3Active, not recruiting
363 participants
Started: Jan 2, 2019 · Completed: Sep 28, 2027
1 condition2 sponsors226 locations
NCT03738774
Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)
N/AActive, not recruiting
200 participants
Started: Jan 2, 2019 · Completed: Jul 31, 2026
1 condition2 sponsors5 locations
NCT02338947
Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients
NAActive, not recruiting
440 participants
Started: Jan 1, 2019 · Completed: Dec 31, 2025
2 conditions5 sponsors7 locations
NCT04470921
STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands
N/AActive, not recruiting
10,000 participants
Started: Jan 1, 2019 · Completed: Dec 31, 2025
2 conditions2 sponsors27 locations
NCT06154057
Retrospective Observational Study of Implant-supported Restorations With Dental Implants.
NAActive, not recruiting
100 participants
Started: Jan 1, 2019 · Completed: Jul 30, 2024
1 condition2 sponsors1 location
NCT06480097
Bidirectional Cohort Study on Improvement of Quality of Life in Patients After Coronary Intervention With Kuanxiong Aerosol
N/AActive, not recruiting
150 participants
Started: Jan 1, 2019 · Completed: Sep 30, 2025
4 conditions1 sponsor1 location
NCT03708965
An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II
PHASE2Active, not recruiting
19 participants
Started: Jan 1, 2019 · Completed: Dec 31, 2027
1 condition1 sponsor2 locations
NCT06461936
Intra-Tumoral Vascular Growth Patterns is a Robust Indicator of Adjuvant Therapy Following Liver Resection in HCC
N/AActive, not recruiting
620 participants
Started: Jan 1, 2019 · Completed: Apr 30, 2025
4 conditions1 sponsor1 location
NCT03906708
Physiological Phenotyping of Respiratory Outcomes in Infants Born Premature
N/AActive, not recruiting
249 participants
Started: Jan 1, 2019 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT04167631
Can VI-RADS/ADC Accurately Stage Bladder Cancer??
NAActive, not recruiting
150 participants
Started: Jan 1, 2019 · Completed: Dec 31, 2024
7 conditions1 sponsor1 location
NCT06402591
Results of Extended Versus Single Dose Antibiotic Prophylaxis In Orthopedic Revision Arthroplasty in Nijmegen.
PHASE3Active, not recruiting
751 participants
Started: Jan 1, 2019 · Completed: Dec 1, 2024
6 conditions2 sponsors1 location
NCT04000607
Exploratory Study of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW Canada)
NAActive, not recruiting
45 participants
Started: Jan 1, 2019 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT03772873
MIPE for Pilonidal Disease
N/AActive, not recruiting
151 participants
Started: Jan 1, 2019 · Completed: Jun 1, 2026
13 conditions2 sponsors10 locations